AUSTIN, TEXAS (March 24, 2008) – Emerson Process Management has entered an agreement with Finesse Solutions, LLC, Irvine, CA, a manufacturer of measurement and control solutions for life sciences process applications. Emerson will provide Finesse’s customers with integration and process automation services between Emerson’s DeltaV digital automation system and Finesse’s TruBio Bioreactor Control System on projects developed by Finesse’s direct sales force for bioprocess drug development and production.

The TruBio system, which is powered by the DeltaV controller, is an "open" configurable software solution developed specifically for the life sciences industry. The embedded configurable control logic for pH, dissolved oxygen, temperature, agitation, and a host of other parameters provides flexible control for both cell culture and fermentation applications.

TruBio is designed to enable OEM's, system integrators, engineering firms and end users alike to quickly customize the control system to meet their individual application requirements. TruBio's open configurable design has the power to compress project schedules and reduce engineering costs while still facilitating customization. Emerson’s role will be to integrate and scale up the embedded DeltaV controller in Finesse’s products into a larger DeltaV system, or expand it to a plant-wide system.

“The agreement between Finesse and Emerson will allow Finesse’s direct sales force to expand the application of the TruBio system from research and development into manufacturing,” said Barb Paldus, CEO of Finesse Solutions. “Life sciences customers will be able to achieve end-to-end process data sharing and faster scale-up through this combined solution.”

“I see this as a positive step forward between our two companies to offer our mutual customers integrated solutions based on Emerson’s PlantWeb technologies,” said Terry Moore, vice president, Life Sciences Industry Center of Emerson Process Management.

PlantWeb is an innovative digital architecture that has been proven in thousands of installations globally, including Life Science applications where benefits include fast startup and operational excellence. PlantWeb is powered by the DeltaV system that digitally networks with Rosemount pressure, flow, level and temperature instruments; Fisher control valves with FIELDVUE digital valve controllers; Micro Motion Coriolis meters and Rosemount analyzers.

About Finesse Solutions
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.

About Emerson Process Management
Emerson Process Management, an Emerson business, is a leader in helping businesses automate their production, processing and distribution in the power, water and wastewater treatment, chemical, oil and gas, refining, pulp and paper, food and beverage, life sciences, and other industries. Emerson brands include PlantWeb, Ovation, SmartProcess, Fisher, Micro Motion, Rosemount, Mobrey, Daniel, Bristol, DeltaV, and AMS Suite.

About Emerson
Emerson (NYSE:EMR), based in St. Louis, is a global leader in bringing technology and engineering together to provide innovative solutions to customers through its network power, process management, industrial automation, climate technologies, and appliance and tools businesses. Sales in fiscal 2007 were $22.6 billion.

Emerson Process Management Contact Information:
Phone Inquiry: 512-835-2190
Emerson Process Management web site

SANTA CLARA, Calif., March 20 /PRNewswire/ -- Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life sciences process applications, is pleased to announce the opening of their new E-Commerce Store effective March 25th. Finesse will be introducing this new E-Store at Interphex in Philadelphia. The new E-Store has been added to the Finesse web site (http://www.finesse.com) so that customers can harness the power of the web and purchase sensors and other accessories on-line.

"We are delighted to open this new E-Store for our customers around the world. Our goal is to enhance the total customer experience and make it as easy as possible for our customers to get what they want, when they want it from Finesse. This E-Store is one of the first steps we will be taking to enhance the overall customer experience at Finesse," said John O'Connell, VP of Sales and Business Development at Finesse Solutions. "Industry acceptance and customer demand has been growing very quickly for our solutions. We need to make sure that our customers can get access to us any time from any place in the world." Customers who visit Finesse at Interphex will be given the opportunity to register for the site and see demonstrations on how to access the site and purchase on line.

About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.

May 2nd , 2008 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the release of TruViu™ PLSS, a vessel utility tower system for pilot and small scale production applications. The PLSS package expands on the RDPD system to include substantially more I/O capability and NEMA 4X enclosures. TruViu™ PLSS consists of an I/O tower, a transmitter tower, an optional pump tower, and/or an optional TruFlow™ gas manifold. TruViu™ PLSS brings the benefits of DeltaV reliability and scalability in an affordable package. It interfaces easily with the TruLogic™ Controller and TruBio™ software to deliver optimal bioprocess control.

TruViu™ PLSS is designed to provide a flexible and plug-and-play configuration, in order to maximize ease-of-use, simplify installation, and provide scheduled maintenance. The modular design allows TruViu™ PLSS components to be mounted on an industrial cart and be used for bioprocess runs on different single-use pilot and small-scale production vessels.

TruViu™ PLSS minimizes floor space while expanding hardware capability to 6 pumps, 6 MFCs, 6 weigh scale inputs, and redundant transmitters for critical process parameters as pH, dissolved oxygen and temperature. TruViu™ PLSS utilizes state-of-the art transmitters that enable sensor calibration algorithms and full sensor diagnostics, and is upgradable to TruFluor disposable sensor technology for single-use applications. TruViu™ PLSS therefore delivers the competitive advantages of increased performance, efficiency and reliability, reduced operating costs and improved ease-of-use in a future-proof package.

According to Finesse Solutions VP Hardware, Dr. Alfy Riddle, "Our end users first asked for low cost and minimal footprint systems, so we developed the TruViu™ RDPD. Then they asked us to expand the hardware capability to take full advantage of our TruBio™ software as well as operate in a wash-down environment. We responded with our TruViu™ PLSS."

About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.

Media: Kimberly Lozada, 408-327-6613

May 05, 2008 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the appointment of Basil Zimmo as its Vice-President of Software. Basil brings over 19 years of international program and senior management experience, with a focus on implementing high efficiency engineering, resource optimization, and global performance metrics. Basil was most recently a Senior Program Manager for handheld products at Research in Motion (RIM). Prior to joining RIM, Basil held senior management roles at Picarro Canada, Inc. and telecommunications companies such as Nortel Networks and JDS Uniphase, and has held positions at semiconductor chip companies such as AMD, Mitel Semiconductor, Phillips Semiconductor, GEC Plessey and Hughes Aircraft Company.

At Finesse Solutions, Mr. Zimmo will lead the new, Santa Clara-based software team in developing the TruBio bioreactor control platform. Mr. Zimmo said, “I am delighted to join Finesse, and work closely with both sensor and hardware teams to develop the next generation TruBio software. Finesse has a unique opportunity to innovate and address the evolving needs of bio-processing applications.”

According to Finesse Solutions CEO Dr. Barbara Paldus, “We are delighted to embark on developing future versions of TruBio software based on state-of-the art programming platforms, that will future-proof our offering and add new capabilities for end users. We look forward to offering end users significantly improved code and novel, advanced features in the near future.”

About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.

Media: Kimberly Lozada, 408-327-6613

April 2, 2008 ─ GE Healthcare has announced a strategic partnership with Finesse Solutions LLC to develop a WAVE BioreactorTM control package based on the Finesse TruLogicTM controller with TruBioTM SCADA.

The TruBio Bioprocess Control Operating System is an open, fully configurable, software solution, developed with GAMP4 methods and validated for cGMP applications. TruBio software is supplied with algorithms for controlling WAVE Bioreactor parameters such as pH, dissolved oxygen, temperature, rocking speed, pressure, aeration, and weight, as well as supporting redundant sensor loops for pH or dissolved oxygen. TruBio software has been optimized for DeltaV-enabled TruLogic Controllers.

Finesse highlighted this collaboration at Interphex by displaying a WAVE BioreactorTM communicating with their TruBio software.

For more information on the various control platforms Finesse offers, visit their website: www.finesse.com

For more information on the WAVE BioreactorTM system and supporting single-use bioprocessing tools, visit the GE Healthcare WAVE Products website:
www.gelifesciences.com/wave

December 4th, 2007 - Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the general release of its TruBio™IOQ package. TruBio™ IOQ is designed to take the guesswork out of validation and to complement thefully configurable TruBio™ operating system (TruBio™ OS).

Traditional validation of control systems can be expensive and time consuming, especially when new documents are created by external validation service contractors. The TruBio™ IOQ package provides all of the protocols needed to validate the maximum process configuration of a specific bioreactor type. By simply choosing the relevant sections and following the pre-written test procedures, end users can complete their installation and operational qualification.

Project managers utilizing TruBio™ IOQ can save valuable project time by eliminating the need to develop validation protocols and by minimizing the validation efforts traditionally found in implementing a new control system. With TruBio™ IOQ, customers can quickly validate TruBio™ OS functionality, minimize down time and improve predictability of the installation schedule.

Upon completing TruBio™ IOQ, users will establish documented evidence assuring that TruBio™ OS meets all user requirements and design specifications. TruBio™ IOQ provides objective evidence that TruBio™ OS performs consistently and accurately per its intended use in the bioprocess application. TruBio™ IOQ follows and incorporates established GAMP4 guidelines to ensure that TruBio™ OS is compliant with FDA’s Title 21 Code of Federal Regulations Parts 11, 210 and 211. TruBio™ IOQ also ensures that the TruBio™ OS will function as specified in cGMP and cGLP environments.

“The days of long and expensive validation are over. TruBio™ IOQ will streamline Installation and Operational Qualifications and at the same time be affordable!” says Yeng Vang, validation manager at Finesse.

About Finesse

California based Finesse leads the way in developing new measurement and control technologies,in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.

April 19, 2007 – Finesse Solutions, LLC, Santa Clara, CA, and Biomedical Resources International,Northborough, MA, have signed a distributor agreement for Finesses’ TrupH™, TruDO™, TruCell2™,TruTransmitter™, TruBio™ OS, TruLogic™ and TruViu™ products for the Life Science market in theNortheast from Maine to Maryland.

The combination of Biomedical Resources years of experience as a supplier of best-in class equipmentto the Life Science market and Finesse’s growing role as a manufacturer of innovative solutions forboth measurement and control in Life Science applications promises to provide end-users with theproducts and support they require to optimize their process while reducing their costs.

“We at Finesse are very pleased to have this opportunity to work with Alan and his team of industryprofessionals at Biomedical Resources. Their commitment to the Life Science industry, appreciationof the industry’s history and understanding of its forward direction is without equal,” said LarryWest, Executive V.P. Sales and Marketing Finesse.

About Finesse
California based Finesse is a global leader in process measurement and control technologies. Ourfamily of products – TruBio™, TruLogic™, TruViu™, TruCell™, TrupH™, and TruDO™, provide comprehensivesolutions for measurement and control processes in the biotech and pharmaceutical industries.

About Biomedical Resources
Biomedical Resources specializes in the Cell Culture and Fermentation marketplace where we offerthe most innovative and cutting edge technology in the BioPharmaceutical industry. In addition toour great assortment of products, Biomedical Resources maintains a staff of highly qualified andtechnical personnel as well as our own Service Department, where we will help provide the mostresponsive and outstanding support available.
Media: Kimberly Lozada, 408-327-6613

December 14th, 2007 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurementand control solutions for life sciences process applications, announced the general release of itsTruViu™ RDPD system for biotech R&D and Process Development (PD) applications. The system consists of an I/O tower and a pump tower, with an optional junction box and TruFlow™ gas manifold,namely, all the components required to control a typical R&D or PD bioreactor.

TruViu™ RDPD is designed to be flexible and modular with plug-and-play configuration, in order to maximize ease-of-use, simplify installation, and provide scheduled maintenance. The modular desig nallows TruViu™ RDPD components to be installed on, under, or above the laboratory bench, thereby permitting a significant footprint reduction and greater lab space efficiency.

TruViu™ RDPD brings the benefits of DeltaV reliability and scalability in an affordable package, and interfaces easily with the TruLogic™ Controller and TruBio™ software to deliver optimal bioreactor control.

TruViu™ RDPD also delivers the competitive advantages of increased performance, efficiency and reliability, reduced operating costs and improved ease of use. Finally, TruViu™ RDPD utilizes state of the art transmitters that enable sensor calibration algorithms and full sensor diagnostics.

“Customer response to TruViu™ RDPD has been overwhelming. They love the idea of a standard, configurable product, and now that our reliable hardware has been repackaged into an efficient footprint our biggest issue is keeping up with demand.” Said Alfy Riddle, VP Hardware.

About Finesse California based Finesse leads the way in developing new measurement and control technologies,in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.

March 7, 2008 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and controlsolutions for life sciences process applications, and Nova Biomedical, Waltham, MA, a world leader inbiotechnology process monitoring announced the first TruBio™ OS plug-in for OPC connectivity betweenTruBio™ OS and Nova BioProfile 400, 100 Plus, Basic 4 and Basic 2 analyzers. Both companies confirmedthat a TruBio™ OS plug-in for OPC connectivity to the Nova Flex is currently in development.OPC (Openness, Productivity and Collaboration) has become the de facto standard for data exchangein process control systems. It has been adopted by the majority of the control system manufacturers inthe bioprocess industry and has proven to be a reliable method for sharing information across differenthardware platforms.

Automatic data exchange using OPC between a lab analyzer and control system reduces errors andtime delays of manual sampling, and provides automated reporting of results. It also allows the controlsystem to adjust process parameters without a 24/7 operator presence, and, in the event of processalarm conditions, alerts off-site personnel and/or takes automatic corrective action.This level of integration enables direct consolidation of off-line lab analyzer results into existing historicaldata collection, automates batch report generation, and creates a complete electronic record. Printouts ofstandalone analyzer results do not have to be manually attached or tracked with electronic batch reportsthat control systems already provide.

“Taking advantage of OPC connectivity between Nova analyzers and the Finesse bioprocess controlsystem will improve quality and yield, while reducing operating costs. For example, programming a Novaanalyzer to automatically standardize an in-situ probe, or using the resulting sample data in real-timecontrol algorithms, will increase both process understanding and control accuracy,” stated Dr. MarkSelker, CTO and co-founder of Finesse.

“By redefining the standard associated with offline data to include complete integration and the value ofthose data as they are applied to the bioprocess automatically, Nova and Finesse continue to provide thecutting edge technology required to bring the biotechnology industry into a new era of effectiveness andprofitability. The value lies in the actions upon that information. Nova and Finesse provide the complimentto each other’s technologies thereby allowing our customers real-time benefits that, until now, wereimpossible.” says Bob Fox, Director of Sales.

About Finesse Solutions, LLCCalifornia-based Finesse Solutions, LLC, leads the way in developing new measurement and controltechnologies, in order to enable the transition to single-use systems, bring new capabilities to existingbioreactor platforms, and harmonize global bio-process information transfer. Our current product familyprovides comprehensive measurement and control solutions for upstream processes in the biotechand pharmaceutical industries. For more information, please visit us at www.finesse.com.

About Nova BiomedicalNova Biomedical is committed to continue its technology leadership with advanced products that providebetter, faster diagnostic information. We continue to innovate biotechnology instruments that allow faster,more economical development of drugs and other therapeutic products.

February 22, 2008 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement andcontrol solutions for life sciences process applications, announced the appointment of John O’Connellas its Vice-President of Sales and Business Development. Mr. O’Connell is a seasoned executive withover 25 years of experience in the automation industry. John was most recently at OSIsoft where hesuccessfully initiated partner programs for strategic customers in the life sciences and power industries.Prior to joining OSIsoft, Mr. O’Connell was a partner at Technology 2 Market a sales and marketingconsulting firm, and held executive positions at Krohne Inc. a leading manufacturer of flow and levelmeasurement systems.

At Finesse Solutions, Mr. O’Connell will be responsible for worldwide sales of sensor and automationsystems products. Mr. O’Connell said, “I am extremely excited to join Finesse, as I believe the companyhas a tremendous opportunity to solve many real-world problems in life science measurement andcontrol applications.”

According to Finesse Solutions CEO Dr. Barbara Paldus, “We are experiencing significant growth asour products are gaining acceptance in the life science industry. We are extremely pleased to havesomeone of John’s caliber join our company, in order to guide the sales organization to meet ouraggressive objectives.”

About FinesseCalifornia-based Finesse Solutions, LLC, leads the way in developing new measurement and controltechnologies, in order to enable the transition to single-use systems, bring new capabilities to existingbioreactor platforms, and harmonize global bio-process information transfer. Our current product familyprovides comprehensive measurement and control solutions for upstream processes in the biotechand pharmaceutical industries.